Metraipolis › archive › dc_7c3fc596ef06

The role of metabolic reprogramming in liver cancer and its clinical perspectives — Europe PMC PMID:39610917

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/39610917
DOI: 10.3389/fonc.2024.1454161
License (as archived): solo-consultazione
Archived: 2026-10-08T05:14:03.097Z
SHA-256 of the archived text: 88a77028f3ac97525211805ae994f91347f628c7e88ba305bc4e4567ec6e2115
Stable URL of this page: https://metraipolis.com/documento/dc_7c3fc596ef06

How to cite

The role of metabolic reprogramming in liver cancer and its clinical perspectives — Europe PMC PMID:39610917 — Europe PMC (en), https://europepmc.org/article/MED/39610917 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c3fc596ef06 (Metraipolis archive dc_7c3fc596ef06, sha256 88a77028f3ac97525211805ae994f91347f628c7e88ba305bc4e4567ec6e2115)

BibTeX

@misc{dc7c3fc596ef06,
  title = {The role of metabolic reprogramming in liver cancer and its clinical perspectives — Europe PMC PMID:39610917},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39610917},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c3fc596ef06; sha256 88a77028f3ac97525211805ae994f91347f628c7e88ba305bc4e4567ec6e2115},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39610917. Agents can read the archived copy with the MCP tool read_document.